Fig. 5From: Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencingClinical actionability of somatic alterations revealed by BTC-PCPD. a Alterations were defined based on their clinical evidence according to OncoKB. b Samples were assigned to the highest level of actionable alterations. c Distribution of levels of actionable alterations. d Distribution of alteration typesBack to article page